Nice to be reminded
Conclusion: Economically, although the net profit per square centimeter of dermal template may favor IDRT, the ancillary benefits associated with BTM in terms of reduced hospital stay, shorter surgery times, fewer follow-up visits, and lower revisionary surgery rates contribute substantially to overall cost-effectiveness. Biodegradable Temporizing Matrix use reflects more efficient resource use and potential cost savings, aligning with broader trends in healthcare emphasizing value-based and patient-centered care.
https://pubmed.ncbi.nlm.nih.gov/38556669/
- Forums
- ASX - By Stock
- The Clinicians Speak
Nice to be remindedConclusion: Economically, although the net...
-
- There are more pages in this discussion • 189 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.53 |
Change
-0.040(1.56%) |
Mkt cap ! $1.756B |
Open | High | Low | Value | Volume |
$2.60 | $2.60 | $2.52 | $1.706M | 666.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
22 | 19715 | $2.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.53 | 5242 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
38 | 11800 | 2.520 |
21 | 31865 | 2.510 |
16 | 54001 | 2.500 |
12 | 222514 | 2.490 |
7 | 9591 | 2.480 |
Price($) | Vol. | No. |
---|---|---|
2.530 | 9448 | 21 |
2.540 | 38531 | 19 |
2.550 | 88246 | 21 |
2.560 | 67171 | 15 |
2.570 | 190637 | 15 |
Last trade - 14.40pm 15/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online